Interviews | Page 15

Teresa Rubio, PharmD of the FDA Office on Health and Constituents Affairs describes the types of adverse drug events that pharmacists should report to MedWatch.
Natasha Nicol, PharmD, FASHP, director of Global Patient Safety Affairs at Cardinal Health, talks about how a pharmacist can be proactive in reducing the chance of errors.
Natasha Nicol, PharmD, FASHP, director of Global Patient Safety Affairs at Cardinal Health, provides prevention strategies to reduce medication errors.
Matthew C. Grissinger, RPh, FISMP, FASCP, director, of error reporting programs at the Institute for Safe Medication Practices, discusses medication use risk outside the pharmacy.
James Hoffman, PharmD, MS, FASHP, describes negative trends affecting the pharmacy workforce.
Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how a patient’s renal function affects appropriate dosing of new oral anticoagulants.
James Hoffman, PharmD, MS, FASHP, explains how pharmacy practice settings may change going forward.
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.
Joel Marrs, PharmD, BCPS-AQ Cardiology, FASHP, discusses the role of the pharmacist in optimizing care for heart failure with reduced ejection fracture patients.
James Hoffman, PharmD, MS, FASHP of St. Jude Children's Research Hospital, outlines how pharmacists can use their knowledge of key trends to patient care improvement efforts.
Latest Issues